The U.S. Food and Drug Administration (FDA) has announced key developments in healthcare, marking advancements in drug treatment, medical device safety, and hygiene technology. Firstly, the FDA approved Fabhalta (iptacopan) for treating complement 3 glomerulopathy (C3G), a rare kidney disorder.
The healthcare industry faces an escalating threat as hackers target electronic health records (EHRs) to steal Drug Enforcement Administration (DEA) registration numbers of physicians. This unauthorized access facilitates the creation and distribution of numerous fraudulent prescriptions, posing
Amid mounting concerns regarding government expenditure, federal spending cuts have started to pose a significant threat to critical medical research funding channeled through the National Institutes of Health (NIH). This alarming reduction in financial support is particularly worrying for diseases
James Maitland is an expert in robotics and IoT applications in medicine, driven by a strong passion for leveraging technology to advance healthcare solutions. Today, we are discussing several aspects of public discourse, vaccine hesitancy, pandemic preparedness, and advancements in immunotherapy.
The Senate recently passed a Continuing Resolution (CR) to prevent a government shutdown and extend crucial healthcare services. The bill now awaits President Donald Trump's signature. This vote, conducted on Friday evening, was a pivotal move to maintain federal operations and healthcare
The recent announcement by Alberta's government to construct two mandatory drug treatment centers in Calgary and Edmonton marks a significant step in the province's strategy to combat the opioid addiction crisis. This proposal, presented by Premier Danielle Smith and Minister of Mental
